- 20 Worst Cars of All Time
- World Wrestling Entertainment (WWE) Stock Jumps Today After Announcing Network Subscriber Milestone
- Advanced Micro Devices (AMD) Stock Continues to Rise Today on Takeover Speculation
- Buy Caterpillar Stock, Collect Its Strong Dividend, Hold for the Long Term
- Advanced Micro Devices (AMD) Stock Spikes Today on Takeover Speculation
The much ballyhooed J.P. Morgan Healthcare Conference kicks off Monday in San Francisco. Here are capsule summaries of some of the expected story lines from presenting companies.
Anti-LINGO-1 is Biogen's most important pipeline drug candidate.
Study results from the most important drug in Biogen Idec's pipeline are expected as early as Monday. Here are essential points you need to know.
With two positive data releases in consecutive days this week, Alkermes is enjoying a strong start to the year.
In a blow to investor transparency, an embarrassingly small number of healthcare companies are webcasting their Q&A breakout sessions at next week's J.P. Morgan Healthcare Conference.
TheStreet's Adam Feuerstein lays down his predictions for the biotech industry for 2015.
Final results from a mid-stage study of Brainstorm's NurOwn therapy show a slowing of disease progression in some ALS patients.
Cempra designed solithromycin to be potent against strains of pneumonia-causing bacteria which have grown resistant to other macrolides.
Once again, biotech stocks greatly outperformed the broader market in 2014.
Another crazy and profitable year in biotech investing was captured 140 characters at a time.